Authors:
Vlastos, G
Jean, ME
Mirza, AN
Mirza, NQ
Kuerer, HM
Ames, FC
Hunt, KK
Ross, MI
Buchholz, TA
Buzdar, AU
Singletary, SE
Citation: G. Vlastos et al., Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases, ANN SURG O, 8(5), 2001, pp. 425-431
Authors:
McMasters, KM
Reintgen, DS
Ross, MI
Wong, SL
Gershenwald, JE
Krag, DN
Noyes, RD
Viar, V
Cerrito, PB
Edwards, MJ
Citation: Km. Mcmasters et al., Sentinel lymph node biopsy for melanoma: How many radioactive nodes shouldbe removed?, ANN SURG O, 8(3), 2001, pp. 192-197
Authors:
Balch, CM
Soong, S
Smith, T
Ross, MI
Urist, MM
Karakousis, CP
Temple, WJ
Mihm, MC
Barnhill, RL
Jewell, WR
Wanebo, HJ
Desmond, R
Citation: Cm. Balch et al., Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas, ANN SURG O, 8(2), 2001, pp. 101-108
Authors:
Porter, GA
Abdalla, J
Lu, MS
Smith, S
Montgomery, D
Grimm, E
Ross, MI
Mansfield, PF
Gershenwald, JE
Lee, JE
Citation: Ga. Porter et al., Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes, ANN SURG O, 8(2), 2001, pp. 116-122
Authors:
Balch, CM
Soong, SJ
Gershenwald, JE
Thompson, JF
Reintgen, DS
Cascinelli, N
Urist, M
McMasters, KM
Ross, MI
Kirkwood, JM
Atkins, MB
Thompson, JA
Coit, DG
Byrd, D
Desmond, R
Zhang, YT
Liu, PY
Lyman, GH
Morabito, A
Citation: Cm. Balch et al., Prognostic factors analysis of 17,600 melanoma patients: Validation of theAmerican Joint Committee on Cancer melanoma staging system, J CL ONCOL, 19(16), 2001, pp. 3622-3634
Authors:
Balch, CM
Buzaid, AC
Soong, SJ
Atkins, MB
Cascinelli, N
Coit, DG
Fleming, ID
Gershenwald, JE
Houghton, A
Kirkwood, JM
McMasters, KM
Mihm, MF
Morton, DL
Reintgen, DS
Ross, MI
Sober, A
Thompson, JA
Thompson, JF
Citation: Cm. Balch et al., Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma, J CL ONCOL, 19(16), 2001, pp. 3635-3648
Authors:
Schlembach, PJ
Buchholz, TA
Ross, MI
Kirsner, SM
Salas, GJ
Strom, EA
McNeese, MD
Perkins, GH
Hunt, KK
Citation: Pj. Schlembach et al., Relationship of sentinel and axillary level I-II lymph nodes to tangentialfields used in breast irradiation, INT J RAD O, 51(3), 2001, pp. 671-678
Authors:
McMasters, KM
Wong, SL
Edwards, MJ
Ross, MI
Chao, C
Noyes, RD
Viar, V
Cerrito, PB
Reintgen, DS
Citation: Km. Mcmasters et al., Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma, SURGERY, 130(2), 2001, pp. 151-156
Authors:
Vlastos, G
Mirza, NQ
Meric, F
Hunt, KK
Kuerer, HM
Ames, FC
Ross, MI
Buchholz, TA
Hortobagyi, GN
Singletary, SE
Citation: G. Vlastos et al., Breast conservation therapy as a treatment option for the elderly - The M.D. Anderson experience, CANCER, 92(5), 2001, pp. 1092-1100
Authors:
Albo, D
Wayne, JD
Hunt, KK
Rahlfs, TF
Singletary, SE
Ames, FC
Feig, BW
Ross, MI
Kuerer, HM
Citation: D. Albo et al., Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer, AM J SURG, 182(4), 2001, pp. 393-398
Authors:
Newman, LA
Kuerer, HM
Fornage, B
Mirza, N
Hunt, KK
Ross, MI
Ames, FC
Buzdar, AU
Singletary, SE
Citation: La. Newman et al., Adverse prognostic significance of infraclavicular lymph nodes detected byultrasonography in patients with locally advanced breast cancer, AM J SURG, 181(4), 2001, pp. 313-318
Authors:
Murray, JL
Hudson, JM
Ross, MI
Zhang, HZ
Ioannides, CG
Citation: Jl. Murray et al., Reduced recognition of metastatic melanoma cells by autologous MART-1 specific CTL: Relationship to TAP expression, J IMMUNOTH, 23(1), 2000, pp. 28-35
Authors:
Kuerer, HM
Hunt, KK
Newman, LA
Ross, MI
Ames, FC
Singletary, SE
Citation: Hm. Kuerer et al., Neoadjuvant chemotherapy in women with invasive breast carcinoma: Conceptual basis and fundamental surgical issues, J AM COLL S, 190(3), 2000, pp. 350-363
Authors:
Mirza, NQ
Vlastos, G
Meric, F
Sahin, AA
Singletary, SE
Newman, LA
Kuerer, HM
Ames, FC
Ross, MI
Feig, BW
Pollock, RE
Buchholz, TA
McNeese, MD
Strom, EA
Hortobagyi, GN
Hunt, KK
Citation: Nq. Mirza et al., Ductal carcinoma-in-situ: Long-term results of breast-conserving therapy, ANN SURG O, 7(9), 2000, pp. 656-664
Authors:
Meric, F
Mirza, NQ
Buzdar, AU
Hunt, KK
Ames, FC
Ross, MI
Pollock, RE
Newman, LA
Feig, BW
Strom, EA
Buchholz, TA
McNeese, MD
Hortobagyi, GN
Singletary, SE
Citation: F. Meric et al., Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer, ANN SURG O, 7(6), 2000, pp. 435-440
Authors:
Porter, GA
Ross, MI
Berman, RS
Lee, JE
Mansfield, PF
Gershenwald, JE
Citation: Ga. Porter et al., Significance of multiple nodal basin drainage in truncal melanoma patientsundergoing sentinel lymph node biopsy, ANN SURG O, 7(4), 2000, pp. 256-261
Authors:
Gershenwald, JE
Berman, RS
Porter, G
Mansfield, PF
Lee, JE
Ross, MI
Citation: Je. Gershenwald et al., Regional nodal basin control is not compromised by previous sentinel lymphnode biopsy in patients with melanoma, ANN SURG O, 7(3), 2000, pp. 226-231
Authors:
Balch, CM
Soong, SJ
Ross, MI
Urist, MM
Karakousis, CP
Temple, WJ
Mihm, MC
Barnhill, RL
Jewell, WR
Wanebo, HJ
Harrison, R
Citation: Cm. Balch et al., Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm), ANN SURG O, 7(2), 2000, pp. 87-97
Authors:
Gershenwald, JE
Mansfield, PF
Lee, JE
Ross, MI
Citation: Je. Gershenwald et al., Role for lymphatic mapping and sentinel lymph node biopsy in patients withthick (>= 4 mm) primary melanoma, ANN SURG O, 7(2), 2000, pp. 160-165